Kintara Therapeutics Announces Data Presentation at the 2022 American Association for Cancer Research Annual Meeting

SAN DIEGO, March 15, 2022 /PRNewswire/ — Kintara Therapeutics, Inc. (Nasdaq: KTRA) ("Kintara" or the "Company"), a biopharmaceutical company focused on the development of new solid tumor cancer therapies, today announces that it will be presenting data at the 2022 American Association…

Click here to view original post